Launch week offerEnds in00h00m00s

annual Promonthly Pro

Rolf I. Skotheim

Professor II

University of Oslo

Norway

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Norway Professors in Medical Imaging Medical Imaging professors in Norway

About

Rolf I. Skotheim is a Professor II at the University of Oslo, Norway. His research primarily focuses on the molecular aspects of cancer, with recent articles addressing prostate cancer biomarkers, the evolution of high-grade serous carcinomas, and the implications of alternative splicing in colorectal cancer. He investigates the genetic and environmental factors contributing to cancer prognosis, particularly in heterogeneous tumor environments.

Articles (17)

Year:

2026

Year:

2026

Year:

2026

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (7)

Ola Myklebost

Senior Scientist

University of Bergen

NORWAY

View details

Jourik A. Gietema

University Medical Center Groningen

NETHERLANDS

View details

Anita Sveen

Group leader of Computational Oncology

University of Oslo

NORWAY

View details

Mark A. Rubin

Professor

University of Bern

SWITZERLAND

View details

Lorenzo Richiardi

Università degli Studi di Torino

ITALY

View details

Trine Berit Haugen

Professor

OsloMet – Oslo Metropolitan University

NORWAY

View details

Ian Mills

VIP, Professor

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rolf I. Skotheim

Research Interests

Make your next move.

Explore related searches

About

Articles (17)

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics

Cell type composition in bulk prostate cancer tissue is a prognostic biomarker

Common gene mutations in 103 authenticated colorectal cancer cell lines

Evolutionary mode and timing of dissemination of high-grade serous carcinomas

GRIN3A: A biomarker associated with a cribriform pattern and poor prognosis in prostate cancer

Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature.

Deviating Alternative Splicing as a Molecular Subtype of Microsatellite Stable Colorectal Cancer

'High proliferative cribriform prostate cancer' defines a patient subgroup with an inferior prognosis.

Expressed prognostic biomarkers for primary prostate cancer independent of multifocality and transcriptome heterogeneity

Re: Spatially resolved clonal copy number alterations in benign and malignant tissue

In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis

Somatic mutations reveal complex metastatic seeding from multifocal primary prostate cancer.

Association study between polymorphisms in DNA methylation-related genes and testicular germ cell tumor risk.

NRF2 drives an oxidative stress response predictive of breast cancer.

Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.

Re: Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.

Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy.

Collaborators (7)

Ola Myklebost

Jourik A. Gietema

Anita Sveen

Mark A. Rubin

Lorenzo Richiardi

Trine Berit Haugen

Ian Mills

Make your next move.